Seeking Alpha
  • Overanalytical
    $MNK down~9% this week. Really glad I only went halfway on this one. Still long
    4/9/13
    Reply (10)
    • gethigh: $MNK is a yo-yo. It liked to bounce around $25 now it's bouncing about $30. Sell your gains when possible, but I'm still long as well.
      4/9/13
    • oneotherfool: Long too. It was downgraded predicting a Q1 miss. Will it miss though? http://bit.ly/12EkHp5
      4/9/13
    • Overanalytical: No I have not seen any believable reason to suggest that sales will be slowing. I agree with the author
      4/9/13
    • oneotherfool: Unfortunately, the stock will have to wait 4 Q1 #s, to climb back up to where it already was 2 weeks ago, rather than picking up from there.
      4/10/13
    • techwonk: Div and buyout potential, but maybe not nxt yr with competitor pipelines at big pharma...what's yr add-on target? I am 1/2 in
      4/11/13
    • Overanalytical: I don't know if I will be adding to my position, however it goes down to 27 or even 26 I might not be able to resist.
      4/11/13
    • techwonk: Two words: vertical integration http://bit.ly/12VrLdp
      4/12/13
    • techwonk: I'm not worried, as long as it stays on Forbes "best small co's" funds will buy. I think it may go under $25 though
      4/12/13
    • techwonk: ...use your own judgment whether to hold or exit and re-enter...
      4/12/13
    • oneotherfool: It hasn't dipped below $25 since Dec. It's possible but I doubt it. I plan on holding & buying more below $27. Let's c what happens next wk.
      4/14/13